Suchergebnisse - Yves Poulin

Treffer weiter einschränken
  1. 1
    Treatment of palmoplantar psoriasis with infliximab: a randomized, double‐blind placebo‐controlled study

    Treatment of palmoplantar psoriasis with infliximab: a randomized, double‐blind placebo‐controlled study von Robert Bissonnette, Yves Poulin, Lyn Guenther, Charles Lynde, Chantal Bolduc, Simon Nigen

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy–assessor‐blinded clinical trial*

    Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy–asses... von Richard B. Warren, Andrew Blauvelt, Yves Poulin, Stefan Beeck, Matt Kelly, Tianshuang Wu, Z. Geng, C. Paul

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from <scp>PHOENIX</scp> 1

    Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from <scp>PHOENIX</scp> 1 von Phoebe Rich, Marc Bourcier, Howard Sofen, Steven Fakharzadeh, Y. Wasfi, Y. Wang, Urs Kerkmann, Pierre‐Dominique Ghislain, Yves Poulin

    Veröffentlicht 2013
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial

    Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial von Boni E. Elewski, Christopher Baker, Jeffrey Crowley, Yves Poulin, Martin M. Okun, Brian Calimlim, Z. Geng, Ofelia Reyes Servín, Phoebe Rich

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)

    Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMP... von Alice B. Gottlieb, Andrew Blauvelt, Diamant Thaçi, Craig L. Leonardi, Yves Poulin, Janice Drew, Luke Peterson, Catherine Arendt, Daniel Burge, Kristian Reich

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Management of acne: Canadian clinical practice guideline

    Management of acne: Canadian clinical practice guideline von Yuka Asai, Akerke Baibergenova, Maha Dutil, Shannon Humphrey, Peter Hull, Charles Lynde, Yves Poulin, Neil H. Shear, Jerry Tan, John Toole, Catherine Zip

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Topical tofacitinib for atopic dermatitis: a phase<scp>II</scp>a randomized trial

    Topical tofacitinib for atopic dermatitis: a phase<scp>II</scp>a randomized trial von Robert Bissonnette, Kim Papp, Yves Poulin, Melinda Gooderham, Maitreyi Raman, Lotus Mallbris, C. Wang, Vivek S. Purohit, Carla Mamolo, Jocelyne Papacharalambous, W.C. Ports

    Veröffentlicht 2016
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial

    TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial von Seth Forman, David M. Pariser, Yves Poulin, Michael S. Vincent, Steven A. Gilbert, Elizabeth Kieras, Ruolun Qiu, Dahong Yu, Jocelyne Papacharalambous, Christopher Tehlirian, Elena Peeva

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Psoriasis Prevalence and Severity by Expert Elicitation

    Psoriasis Prevalence and Severity by Expert Elicitation von Kim Papp, Robert Gniadecki, Jennifer Beecker, Jan Dutz, Melinda Gooderham, Chih-ho Hong, Mark G. Kirchhof, C. Lynde, Catherine Maari, Yves Poulin, Ronald Vender

    Veröffentlicht 2021
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    A New Calcipotriol/Betamethasone Formulation with Rapid Onset of Action was Superior to Monotherapy with Betamethasone Dipropionate or Calcipotriol in Psoriasis Vulgaris

    A New Calcipotriol/Betamethasone Formulation with Rapid Onset of Action was Superior to Monotherapy with Betamethasone Dipropionate or Calcipotriol in Psoriasis Vulgaris von W.S. Douglas, Yves Poulin, J. Decroix, J.‐P. Ortonne, Ulrich Mrowietz, Wayne Gulliver, Anne‐Lene Krogstad, Frederik Grønhøj Larsen, Lisett González Iglesias, C. Buckley, A. Bibby

    Veröffentlicht 2002
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial

    Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial von Boni E. Elewski, Martin M. Okun, Kim Papp, Christopher Baker, Jeffrey Crowley, G. Guillet, Murali Sundaram, Yves Poulin, Yihua Gu, Ziqian Geng, David Williams, Phoebe Rich

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus

    Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus von Jonathan I. Silverberg, Andreas Pinter, Grażyna Pulka, Yves Poulin, Jean‐David Bouaziz, Andreas Wollenberg, Dédée F. Murrell, Andrew Alexis, Lisa Lindsey, Faiz Ahmad, Christophe Piketty, Alan Clucas

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up

    Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of... von Richard Langley, Mark Lebwohl, Gerald G. Krueger, Philippe Szapary, Y. Wasfi, Daphne Chan, Ming-Chun Hsu, Yin You, Yves Poulin, Neil J. Korman, Jörg C. Prinz, Kristian Reich

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

    Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis von Andrew Blauvelt, Kim Papp, Howard Sofen, Matthias Augustin, Gil Yosipovitch, Norito Katoh, Ulrich Mrowietz, Mamitaro Ohtsuki, Yves Poulin, David Shrom, Russel Burge, Kyoungah See, Lotus Mallbris, Kenneth B. Gordon

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)

    Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled tri... von C. Paul, Jennifer Clay Cather, Melinda Gooderham, Yves Poulin, Ulrich Mrowietz, Carlos Montilla, J. Crowley, ChiaChi Hu, R.M. Stevens, Kara N. Shah, R. M. Day, Giampiero Girolomoni, A.B. Gottlieb

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council

    Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council von Bruce Strober, P.C.M. van de Kerkhof, Kristina Callis Duffin, Yves Poulin, Richard B. Warren, Claudia de la Cruz, Joelle M. van der Walt, Bradley S. Stolshek, Mona Martin, André Vicente Esteves de Carvalho

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis

    A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis von Eric L. Simpson, Shinichi Imafuku, Yves Poulin, Benjamin Ungar, Lisa Zhou, Kunal Malik, Huei‐Chi Wen, Hui Xu, Yeriel Estrada, Xiangyu Peng, Mindy Chen, N.J. Shah, Mayte Suárez‐Fariñas, Ana B. Pavel, Kristine Nograles, Emma Guttman‐Yassky

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial

    Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial von Bárður Sigurgeirsson, Andrzej Boznański, Gail Todd, André Vertruyen, Marie L. A. Schuttelaar, Xuejun Zhu, U. Schauer, Paul Y. Qaqundah, Yves Poulin, Sigurður Kristjánsson, Andrea von Berg, Antonio Nieto, Mark Boguniewicz, Amy S. Paller, Rada Dakovic, Johannes Ring, Thomas A. Luger

    Veröffentlicht 2015
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

    North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations von Ali Alikhan, Christopher Sayed, Afsáneh Alavi, Raed Alhusayen, Alain Brassard, Craig N. Burkhart, Karen Crowell, Daniel B. Eisen, Alice B. Gottlieb, Iltefat Hamzavi, Paul G. Hazen, Tara Jaleel, Alexa B. Kimball, Joslyn S. Kirby, Michelle A. Lowes, Robert G. Micheletti, Angela P. Miller, Haley B. Naik, Dennis P. Orgill, Yves Poulin

    Veröffentlicht 2019
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  20. 20
    North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

    North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations von Ali Alikhan, Christopher Sayed, Afsáneh Alavi, Raed Alhusayen, Alain Brassard, Craig N. Burkhart, Karen Crowell, Daniel B. Eisen, Alice B. Gottlieb, Iltefat Hamzavi, Paul G. Hazen, Tara Jaleel, Alexa B. Kimball, Joslyn S. Kirby, Michelle A. Lowes, Robert G. Micheletti, Angela P. Miller, Haley B. Naik, Dennis P. Orgill, Yves Poulin

    Veröffentlicht 2019
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: